Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Ralph Baric

University of California Berkeley, Department: Internal Medicine/medicine

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Takeda Vaccines Inc.

Disclosed Value
Listed Reason
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution

The SFI of the investigator is related to the funded research since the technology being used in the project has been licensed to the company with which the investigator has a funding relationship. The Institution has determined that since the technology could be further validated as a result of the research, these financial interests could conflict with project.

Listed Research Project
Protective immunity following dengue virus natural infections and vaccination

Dengue is a major public health problem worldwide and is complicated by four distinct yet cross-reactive serotypes. This P01 addresses the critical need to improve understanding of the human B and T cell response to dengue virus infection and vaccination and to identify immune correlates of protection from disease. To this end, our consortium of world-renowned investigators is applying state-of-the-art immunological methods in the context of long-term ongoing clinical and epidemiological studies of dengue and Phase 2 and 3 trials of dengue vaccines.

Filed on August 28, 2017.

Tell us what you know about Ralph Baric's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Ralph Baric Univ of North Carolina Chapel Hill Conflict of Interest Takeda Vaccines, Inc. $0 - $4,999
Ralph Baric Univ of North Carolina Chapel Hill Conflict of Interest Takeda Vaccines, Inc $0 - $4,999
Ralph Baric Univ of North Carolina Chapel Hill Conflict of Interest Takeda Vaccines, Inc. $0 - $4,999
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page